Navidea Biopharmaceuticals, Inc (NAVB) stock price moved 11.07% away from 20-Days Simple Moving Average, -18.24% from 50-Days Simple Moving Average and separated -35.81% from 200 Days Simple Moving Average. Navidea Biopharmaceuticals, Inc (NAVB) reported gain 0.43% in recent buying and selling session with closing price of $ 0.14. The stock’s traded 0.26 million shares in session while it holds an average volume of 0.66 million shares. The NAVB switched 39.40% away from its 52 week minimum and distanced -66.97% from its 52 week peak. The volatility change in the previous week has observed by 12.90% and experienced of 14.61% change in the last month.
The short ratio in the company’s stock is documented at 10.65 and the short float is around of 5.10%. Beta factor, which measures the riskiness of the security, was registered at 0.31. The Company kept a record of 138.65 million floated shares and 174.29 million shares outstanding. The average true range of the stock is observed at 0.02 and the relative strength index of the stock is recorded at 48.59.
Navidea Biopharmaceuticals, Inc (NAVB) Stock Profitability Levels:
Gross profit margin is 94.60%. The larger the gross profit margin, the better for the company. The company made Return on equity of -355.90% in last 12 months period. Return on assets ratio of the Company was -119.60%. Its return on investment ratio was -101.60% in the trailing 12 months period.
The Company’s sales have grown at an average annualized rate of about 87.20% during the past five years. For the past 5 years, The Company’s EPS growth has been nearly 22.00%. Analyst established EPS growth expected to grow of -79.00% for this year.
Looking about the past performance history, the company jumped 10.31% for the last five trades and expanded 0.65% in one month period. The stock deteriorated -47.01% during the past three month period and discounted -31.02% in half year. During the yearly overview it downgraded -63.97% and shown 36.48% year to date performance.